Stocks of Axis Capital Holdings Ltd (AXS) are poised to climb above their peers

With 0.68 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.6 million shares. The 52-week range on AXS shows that it touched its highest point at $63.93 and its lowest point at $51.25 during that stretch. It currently has a 1-year price target of $68.86. With its current market cap of 5.02 billion, AXS has annualized dividend of $1.81 while the current yield stands at 3.08%. Beta for the stock currently stands at 0.79.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AXS was down-trending over the past week, with a drop of -1.14%, but this was up by 5.22% over a month. Three-month performance surged to 9.33% while six-month performance rose 7.06%. The stock lost -3.30% in the past year, while it has gained 6.27% so far this year. A look at the trailing 12-month EPS for AXS yields 4.01 with Next year EPS estimates of 10.41. For the next quarter, that number is 2.59. This implies an EPS growth rate of 76.12% for this year and 4.62% for next year. EPS is expected to grow by 20.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 286.70%.

Float and Shares Shorts:

At present, 85.29 million AXS shares are outstanding with a float of 77.26 million shares on hand for trading. On Jan 11, 2024, short shares totaled 1.04 million, which was 1.22% higher than short shares on Dec 14, 2023. In addition to AXSM as the firm’s Axsome Therapeutics, Inc., AXP serves as its American Express Company.

Institutional Ownership:

Through their ownership of 93.02% of AXS’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AXS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AXS analysts setting a high price target of $80.00 and a low target of $52.00, the average target price over the next 12 months is $68.86. Based on these targets, AXS could surge 35.96% to reach the target high and fall by -11.62% to reach the target low. Reaching the average price target will result in a growth of 17.03% from current levels.

Summary of Insider Activity:

Insiders traded AXS stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 2 while that of sell transactions has risen to 9 over the past year. The total number of shares bought during that period was 21,866 while 58,346 shares were sold.